Literature DB >> 28381129

Compression Decreases Anatomical and Functional Recovery and Alters Inflammation after Contusive Spinal Cord Injury.

Michael B Orr1,2, Jennifer Simkin1,3, William M Bailey1, Neha S Kadambi4, Anna Leigh McVicar1, Amy K Veldhorst1, John C Gensel1.   

Abstract

Experimental models of spinal cord injury (SCI) typically utilize contusion or compression injuries. Clinically, however, SCI is heterogeneous and the primary injury mode may affect secondary injury progression and neuroprotective therapeutic efficacy. Specifically, immunomodulatory agents are of therapeutic interest because the activation state of SCI macrophages may facilitate pathology but also improve repair. It is unknown currently how the primary injury biomechanics affect macrophage activation. Therefore, to determine the effects of compression subsequent to spinal contusion, we examined recovery, secondary injury, and macrophage activation in C57/BL6 mice after SCI with or without a 20 sec compression at two contusion impact forces (50 and 75 kdyn). We observed that regardless of the initial impact force, compression increased tissue damage and worsened functional recovery. Interestingly, compression-dependent damage is not evident until one week after SCI. Further, compression limits functional recovery to the first two weeks post-SCI; in the absence of compression, mice receiving contusion SCI recover for four weeks. To determine whether the recovery plateau is indicative of compression-specific inflammatory responses, we examined macrophage activation with immunohistochemical markers of purportedly pathological (CD86 and macrophage receptor with collagenous structure [MARCO]) and reparative macrophages (arginase [Arg1] and CD206). We detected significant increases in macrophages expression of MARCO and decreases in macrophage Arg1 expression with compression, suggesting a biomechanical-dependent shift in SCI macrophage activation. Collectively, compression-induced alterations in tissue and functional recovery and inflammation highlight the need to consider the primary SCI biomechanics in the design and clinical implementation of immunomodulatory therapies.

Entities:  

Keywords:  infinite horizons; inflammation; mice; microglia

Mesh:

Year:  2017        PMID: 28381129      PMCID: PMC5549830          DOI: 10.1089/neu.2016.4915

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  47 in total

Review 1.  Repertoire of microglial and macrophage responses after spinal cord injury.

Authors:  Samuel David; Antje Kroner
Journal:  Nat Rev Neurosci       Date:  2011-06-15       Impact factor: 34.870

2.  Histological and functional evaluation of experimental spinal cord injury: evidence of a stepwise response to graded compression.

Authors:  J A Gruner; A K Yee; A R Blight
Journal:  Brain Res       Date:  1996-08-05       Impact factor: 3.252

3.  The influence of spinal canal narrowing and timing of decompression on neurologic recovery after spinal cord contusion in a rat model.

Authors:  J R Dimar; S D Glassman; G H Raque; Y P Zhang; C B Shields
Journal:  Spine (Phila Pa 1976)       Date:  1999-08-15       Impact factor: 3.468

4.  Secondary pathology following contusion, dislocation, and distraction spinal cord injuries.

Authors:  Anthony M Choo; Jie Liu; Marcel Dvorak; Wolfram Tetzlaff; Thomas R Oxland
Journal:  Exp Neurol       Date:  2008-05-14       Impact factor: 5.330

5.  Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.

Authors:  Andrew D Greenhalgh; Rosmarini Passos Dos Santos; Juan Guillermo Zarruk; Christopher K Salmon; Antje Kroner; Samuel David
Journal:  Brain Behav Immun       Date:  2016-04-25       Impact factor: 7.217

6.  Molecular, anatomical, physiological, and behavioral studies of rats treated with buprenorphine after spinal cord injury.

Authors:  José M Santiago; Odrick Rosas; Aranza I Torrado; María M González; Priya O Kalyan-Masih; Jorge D Miranda
Journal:  J Neurotrauma       Date:  2009-10       Impact factor: 5.269

7.  Histological effects of residual compression sustained for 60 minutes at different depths in a novel rat spinal cord injury contusion model.

Authors:  Simon G Sjovold; Stephen F E Mattucci; Anthony M Choo; Jie Liu; Marcel F Dvorak; Brian K Kwon; Wolfram Tetzlaff; Thomas R Oxland
Journal:  J Neurotrauma       Date:  2013-07-17       Impact factor: 5.269

8.  Different TLR4 expression and microglia/macrophage activation induced by hemorrhage in the rat spinal cord after compressive injury.

Authors:  Yu-Kai Zhang; Jin-Tao Liu; Zheng-Wu Peng; Hong Fan; An-Hui Yao; Peng Cheng; Ling Liu; Gong Ju; Fang Kuang
Journal:  J Neuroinflammation       Date:  2013-09-10       Impact factor: 8.322

9.  MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis.

Authors:  Dawn M E Bowdish; Kaori Sakamoto; Mi-Jeong Kim; Mariliis Kroos; Subhankar Mukhopadhyay; Cynthia A Leifer; Karl Tryggvason; Siamon Gordon; David G Russell
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

10.  Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury.

Authors:  Bei Zhang; William M Bailey; Timothy J Kopper; Michael B Orr; David J Feola; John C Gensel
Journal:  J Neuroinflammation       Date:  2015-11-24       Impact factor: 8.322

View more
  10 in total

Review 1.  Myelin as an inflammatory mediator: Myelin interactions with complement, macrophages, and microglia in spinal cord injury.

Authors:  Timothy J Kopper; John C Gensel
Journal:  J Neurosci Res       Date:  2017-07-11       Impact factor: 4.164

2.  Reducing age-dependent monocyte-derived macrophage activation contributes to the therapeutic efficacy of NADPH oxidase inhibition in spinal cord injury.

Authors:  Bei Zhang; William M Bailey; Anna Leigh McVicar; Andrew N Stewart; Amy K Veldhorst; John C Gensel
Journal:  Brain Behav Immun       Date:  2018-11-16       Impact factor: 7.217

3.  Depletion of astrocytic transglutaminase 2 improves injury outcomes.

Authors:  Alina Monteagudo; Julianne Feola; Heather Natola; Changyi Ji; Christoph Pröschel; Gail V W Johnson
Journal:  Mol Cell Neurosci       Date:  2018-06-30       Impact factor: 4.314

Review 4.  Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses.

Authors:  Michael B Orr; John C Gensel
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

5.  Phrenic motor neuron survival below cervical spinal cord hemisection.

Authors:  Latoya L Allen; Nicole L Nichols; Zachary A Asa; Anna T Emery; Marissa C Ciesla; Juliet V Santiago; Ashley E Holland; Gordon S Mitchell; Elisa J Gonzalez-Rothi
Journal:  Exp Neurol       Date:  2021-08-05       Impact factor: 5.620

6.  Thrombospondin-1 modified bone marrow mesenchymal stem cells (BMSCs) promote neurite outgrowth and functional recovery in rats with spinal cord injury.

Authors:  Yujie Pu; Ke Meng; Chuanlong Gu; Linlin Wang; Xiaoming Zhang
Journal:  Oncotarget       Date:  2017-10-24

7.  Interactions of primary insult biomechanics and secondary cascades in spinal cord injury: implications for therapy.

Authors:  Michael B Orr; John C Gensel
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

8.  Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord.

Authors:  Arshia Ehsanipour; Mayilone Sathialingam; Laila M Rad; Joseph de Rutte; Rebecca D Bierman; Jesse Liang; Weikun Xiao; Dino Di Carlo; Stephanie K Seidlits
Journal:  APL Bioeng       Date:  2021-03-09

9.  miRNA-221 Regulates Spinal Cord Injury-Induced Inflammatory Response through Targeting TNF-α Expression.

Authors:  Feng Sun; Haiwei Zhang; Tianwen Huang; Jianhui Shi; Tianli Wei; Yansong Wang
Journal:  Biomed Res Int       Date:  2021-04-07       Impact factor: 3.411

10.  Botulinum Toxin Type A Possibly Affects Cav3.2 Calcium Channel Subunit in Rats with Spinal Cord Injury-Induced Muscle Spasticity.

Authors:  Kening Ma; Dan Zhu; Chunguo Zhang; Lijie Lv
Journal:  Drug Des Devel Ther       Date:  2020-07-28       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.